Search Results - COLEVAS, A. Dimitri

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    A prospective study of electronic quality of life assessment using tablet devices during and after treatment of head and neck cancers

    A prospective study of electronic quality of life assessment using tablet devices during and after treatment of head and neck cancers by Pollom, Erqi L, Wang, Ellen, Bui, Timothy T, Ognibene, Grant, von Eyben, Rie, Divi, Vasu, Sunwoo, John, Kaplan, Michael, Dimitri Colevas, A, Le, Quynh-Thu, Hara, Wendy Y

    Published in Oral oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Sequential Flavopiridol, Cytosine Arabinoside, and Mitoxantrone: A Phase II Trial in Adults with Poor-Risk Acute Myelogenous Leukemia

    Sequential Flavopiridol, Cytosine Arabinoside, and Mitoxantrone: A Phase II Trial in Adults with Poor-Risk Acute Myelogenous Leukemia by KARP, Judith E, SMITH, B. Douglas, LEVIS, Mark J, GORE, Steven D, GREER, Jacqueline, HATTENBURG, Catherine, BRIEL, Janet, JONES, Richard J, WRIGHT, John J, COLEVAS, A. Dimitri

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    BRAF inhibitor treatment of primary BRAF-mutant ameloblastoma with pathologic assessment of response

    BRAF inhibitor treatment of primary BRAF-mutant ameloblastoma with pathologic assessment of response by Tan, Serena, Pollack, Jonathan R, Kaplan, Michael J, Colevas, A. Dimitri, West, Robert B

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    BRAF-Inhibitor Therapy of Primary Ameloblastoma

    BRAF-Inhibitor Therapy of Primary Ameloblastoma by West, Robert B., M.D, Tan, Serena, Pollack, Jonathan R, Kaplan, Michael J, Colevas, A.D

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Abstract CT047: A phase 2 study of ipatasertib in combination with pembrolizumab for first line treatment of recurrent or metastatic squamous cell cancer of the head and neck

    Abstract CT047: A phase 2 study of ipatasertib in combination with pembrolizumab for first line treatment of recurrent or metastatic squamous cell cancer of the head and neck by Thomas, Jacob S., Hsu, Robert, Villaflor, Victoria, Riess, Jonathan, Nieva, Jorge, Krailo, Mark, Gutkind, Silvio, Colevas, Dimitri

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    HPV-Associated Oropharyngeal Cancer Tumor Board

    HPV-Associated Oropharyngeal Cancer Tumor Board by Nussenbaum, Brian, Weinstein, Gregory S., Girod, Douglas A., Bradford, Carol R., Hinni, Michael L., Colevas, Dimitri, Yom, Sue

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Phase I Trial of Bortezomib (NSC 681239) and Flavopiridol (NSC 649890) in Patients with Recurrent or Refractory Indolent B-Cell Neoplasms

    Phase I Trial of Bortezomib (NSC 681239) and Flavopiridol (NSC 649890) in Patients with Recurrent or Refractory Indolent B-Cell Neoplasms by Grant, Steven, Sullivan, Daniel, Roodman, David, Stuart, Robert K, Perkins, Edward, Kolla, Sarah, Ramakrishnan, Viswanathan, Wright, John, Colevas, Alexander Dimitri, Tombes, M B, Roberts, John D

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: